Research
The Cancer Vaccine Institute (CVI) is the only national charity in the UK exclusively funding research to fight cancer with vaccines and immunotherapy. The ultimate aim is that vaccines will increase survival rates and patients’ quality of life. The CVI funds both laboratory research and clinical trials and is currently funding or aims to fund trials to develop cancer vaccines for: malignant melanoma; brain; and childhood cancers. These cancers do not respond well to conventional treatments especially when they spread around the body (secondary cancers).
The Research is undertaken by Professor Angus Dalgleish Bsc (Hons) MBBS MD FRACPath FRACP FRCP FMed Sci and his team at St George's University of London and at other centres around the country. A Scientific Board, made up of a panel of scientists and clinicians is responsible for independently assessing and prioritising research projects.
Laboratory work and early clinical studies for dendritic cell based vaccines, funded by the CVI and around the world, have demonstrated that good and occasional dramatic clinical responses can be achieved and that there are no significant side-effects.
We rely solely on voluntary contributions to fund our Research costs which include laboratory and out-patient facilities, consumables and salaries of the research team.
.
